PDHB and nonpapillary renal cell carcinoma: From TCGA-ccRCC database, we found that the patients with low level of PDHB displayed poor prognosis in overall survival (OS), disease-specific survival (DSS) and progression free interval (PFI) (Figures 5A–C).